Stock SYNT SYNTHOMER PLC
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Synthomer plc

Equities

SYNT

GB00BNTVWJ75

Market Closed - London S.E.
Other stock markets
 16:35:11 26/04/2024 BST 		5-day change 1st Jan Change
235.5 GBX +1.51% Intraday chart for Synthomer plc -1.26% +24.14%
04-17 EARNINGS AND TRADING: Chill Brands shareholder seeks board ejections AN
04-15 Synthomer sells latex compounding operations for EUR27.5 million AN

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.43 for the 2023 fiscal year.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the past twelve months, EPS forecast has been revised upwards.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • Low profitability weakens the company.
  • The company is in debt and has limited leeway for investment
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
SYNTHOMER PLC Stock Synthomer plc
+24.14% 480M
B
ECOLAB INC. Stock Ecolab Inc.
+11.47% 63.22B
A-
SIKA AG Stock Sika AG
-3.47% 46.34B
A-
GIVAUDAN SA Stock Givaudan SA
+13.72% 39.97B
B+
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+17.83% 25.46B
A-
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.27% 18.68B
C+
CELANESE CORPORATION Stock Celanese Corporation
-0.57% 17.24B
B+
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.73% 15.81B
A-
SYMRISE AG Stock Symrise AG
+0.22% 14.9B
B+
ALBEMARLE CORPORATION Stock Albemarle Corporation
-19.10% 13.74B
C+
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. SYNT Stock
  4. Ratings Synthomer plc